Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples

Part of paid clinical trials in Stanford, California.

Sponsor
Stanford University
Study ID
NCT01034033
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The purpose of this study is to try to understand the biology of development of breast, ovarian, fallopian tube, peritoneal or endometrial cancer from persons at high genetic risk for these diseases. The influence of environmental factors on cancer development in individuals and families will be studied. The efficacy of treatments for these diseases will be evaluated.

Key Dates

Start date
Aug 31, 2001
Status verified
May 2026
Primary completion
Jan 31, 2099
Completion
Jan 31, 2099

Study Design

Enrollment
3,300 participants (estimated)

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Stanford University School of MedicineStanfordCalifornia94305
Meredith Mills
[email protected]
650-724-5223
James M Ford (PRINCIPAL_INVESTIGATOR)
Allison Walsh Kurian (SUB_INVESTIGATOR)

Find similar trials in Stanford, CA

By condition
Breast cancerOvarian cancer
By specialty
OncologyBreast oncologyWomen's healthGynecologic oncology
By research site
Stanford University School of Medicine· Stanford, CA

Related Studies